File pic shows Pfizer Covid-19 vaccine vials
WASHINGTON: The U.S. Food and Drug Administration (FDA) on Wednesday authorized Pfizer's antiviral COVID-19 pill, making it the first at-home treatment that is expected to become an important tool in the fight against the Omicron variant.
A panel of expert advisers to the FDA has also recommended the agency authorize Merck & Co's experimental antiviral pill molnupiravir, which has already received regulatory approvals in Britain, Denmark and Philippines among others.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
